NCT06682507 High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
| NCT ID | NCT06682507 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital, Sun Yat-Sen University |
| Condition | Lupus Nephritis (LN) |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 1996-01-01 |
| Primary Completion | 2050-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 1996-01-01 with a primary completion date of 2050-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the long-term renal and patient's survival of lupus nephritis (LN) patients in China. The main question it aims to answer is: Does the renal and patient's survival improved in the long term period? Participants who had renal biopsy proven lupus nephritis in one hospital will be followed up.
Eligibility Criteria
Inclusion Criteria: Patients who had biopsy proven lupus nephritis in The First Affiliated Hospital of Sun Yat-sen University Exclusion Criteria: * less than 14 years old * refused to give written consent
Contact & Investigator
Wei Chen, MD PHD
PRINCIPAL INVESTIGATOR
First Affiliated Hospital, Sun Yat-Sen University
Frequently Asked Questions
Who can join the NCT06682507 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying Lupus Nephritis (LN). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06682507 currently recruiting?
Yes, NCT06682507 is actively recruiting participants. Contact the research team at xiax29@mail.sysu.edu.cn for enrollment information.
Where is the NCT06682507 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06682507 clinical trial?
NCT06682507 is sponsored by First Affiliated Hospital, Sun Yat-Sen University. The principal investigator is Wei Chen, MD PHD at First Affiliated Hospital, Sun Yat-Sen University. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.